UBE4B and neuroblastoma: We believe that neuroblastoma tumorigenesis is promoted by a coordinated network of intracellular signaling pathways whose activities are altered by reduced UBE4B expression and loss of UBE4B ubiquitin ligase activity in high-risk neuroblastoma tumors and that these UBE4B-mediated pathways directly impact neuroblastoma patient outcomes.